Bare lurte på om noen hadde testet ut dette stoffet?
"URB597 was discovered in 2007 in California by Daniel Piomelli and his colleagues. They were carrying out huge investigation of human brain where they found the substance called anandamide. Anandamide is a cannabinoid neurotransmitter that has similar effect to marihuana but is produced by human brain.
URB597 suppresses production of fatty acid amide hydrolase or FAAH which causes the degradation of anandamide. That produces antidepressant effect. This effect is similar to marihuana effect but is generated naturally by human body. URB597 also stimulates digestion and helps to solve problems with overweight.
URB597 was tested on rats that were exposed to stress during 5 days. During this period of time they were given URB-597. As a result they became more stress resistant and less aggressive. In 2007
URB597 got the patent. Pharmaceutical company Organon bought the right to start clinical research in 2008.
Although in many European countries as well in the United States and Canada marihuana is allowed as a pain killer and antidepressant to treat several forms of diseases still such treatment has a negative side effect. Scientists claim that new medicine on the basis of URB597 will have no side effects as its effect will be based on natural processes in human body."
"URB597 was discovered in 2007 in California by Daniel Piomelli and his colleagues. They were carrying out huge investigation of human brain where they found the substance called anandamide. Anandamide is a cannabinoid neurotransmitter that has similar effect to marihuana but is produced by human brain.
URB597 suppresses production of fatty acid amide hydrolase or FAAH which causes the degradation of anandamide. That produces antidepressant effect. This effect is similar to marihuana effect but is generated naturally by human body. URB597 also stimulates digestion and helps to solve problems with overweight.
URB597 was tested on rats that were exposed to stress during 5 days. During this period of time they were given URB-597. As a result they became more stress resistant and less aggressive. In 2007
URB597 got the patent. Pharmaceutical company Organon bought the right to start clinical research in 2008.
Although in many European countries as well in the United States and Canada marihuana is allowed as a pain killer and antidepressant to treat several forms of diseases still such treatment has a negative side effect. Scientists claim that new medicine on the basis of URB597 will have no side effects as its effect will be based on natural processes in human body."
